fda approval, page-3

"Data gathered as of Sept. 14 showed a 64 percent success rate for the HeartMate II device, just below a pre-specified goal of 65 percent, Food and Drug Administration staff said in a summary prepared for an advisory panel review."


If Thoratec gets approval it must be good news for VCR
Their last statement showed survival being 83% at 6 months and 75% at one year.
Much better odds than the Heartmate II device.

:-)